Clinical Trials

Text Size A A

E-Mail to a Friend



secret  Click to Play Audio


Send To Friend

Myelodysplastic/Myeloproliferative Syndromes

Early Discharge and Outpatient Care MDS and AML Patients
Phase 2 Study of Early Discharge and Outpatient Management of Adult Patients Following Intensive Chemotherapy for MDS and Non-APL AML
Status Conditions Phase Study ID
Recruiting Myelodysplastic Syndromes
Leukemia		 Phase II NCT01235572
Summary

RATIONALE: Gathering information about patients with myelodysplastic syndrome or acute myeloid leukemia who are discharged after finishing chemotherapy, or who stay in the hospital until blood counts return to normal, may help doctors learn more about the safety of allowing patients to leave the hospital early, the patient's quality of life, use of medical services, and the cost of these services associated with such a policy.

PURPOSE: This clinical trial is studying early discharge and outpatient care in patients who have undergone chemotherapy for myelodysplastic syndrome or acute myeloid leukemia.



Investigator
Roland B. Walter, MD, PhD
Location    
Seattle Cancer Care Alliance 800-804-8824  
Eligibility Criteria (must meet the following to participate in this study)
  • Age 18-75 years.
  • Diagnosis of MDS or AML other than APL with t(15;17)(q22;q12), (PML/RAR), or variants according to the 2008 WHO classification.
  • Will undergo AML-like intensive induction, re-induction, or consolidation chemotherapy within 1 week, or have started therapy within last 72 hours.

 

 


Exclusions (conditions that would prevent participation in this study)
- Drug hypersensitivities or allergies disabling use of prophylactic antimicrobials.
Last Updated
June 05, 2012
See this trial at ClinicalTrials.gov
Access protocol and consent forms at Fred Hutchinson Cancer Research Center
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:
  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.